Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant Prizm 2, HE AICD Launches Will Benefit From Sales Force Expansion

This article was originally published in The Gray Sheet

Executive Summary

Guidant's planned expansion of its Cardiac Rhythm Management sales force will support the U.S. launch of the Ventak Prizm 2 and Prizm HE dual-chamber automatic implantable cardioverter defibrillators, approved on Aug. 8 and on Aug. 9, respectively.
Advertisement

Related Content

Guidant's Ventak Prizm 2
Guidant's Ventak Prizm 2
Guidant Tetra Stent Approval Opens Opportunity To Recoup Lost Market Share
Guidant Tetra Stent Approval Opens Opportunity To Recoup Lost Market Share
UK's NICE Could Issue ICD Guidance As Early As Sept. 25 - ABHI Officials
Guidant Ventak Prizm 2
UK's NICE Could Issue ICD Guidance As Early As Sept. 25 - ABHI Officials
Guidant Ventak Prizm 2
Advertisement
UsernamePublicRestriction

Register

MT013728

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel